402
Citations
127
Journals
2006
First Cited
2022
Last Cited

Articles citing This Document (Page 3 of 9)

ArticleJournalYear
Synoptic CT scan reporting of pancreatic adenocarcinoma to align with international consensus guidelines on surgical resectability: a Victorian pilot
Neoadjuvant chemotherapy or upfront surgery in localized pancreatic cancer: a contemporary analysis2022
Prognostic factors in conversion surgery following nab‐paclitaxel with gemcitabine and subsequent chemoradiotherapy for unresectable locally advanced pancreatic cancer: Results of a dual‐center study
Stereotactic Body Radiotherapy for Locally Advanced Pancreatic Cancer Using Optical Surface Management System – AlignRT as an Optical Body Surface Motion Management in Deep Breath Hold Patients: Results from a Single-Arm Retrospective StudyCancer Management and Research
Precision Approaches to Pancreatic Cancer Therapy: What Now and What Next?Current Treatment Options in Gastroenterology
The Future Perspectives of Redefining the Resection Margin Status in Different Cancers of PancreasOpen Access Macedonian Journal of Medical Sciences2022
A Prospective Study of Neoadjuvant Gemcitabine Plus Nab-paclitaxel in Patients with Borderline-resectable Pancreatic CancerInternal Medicine2022
Adaptive Dynamic Therapy and Survivorship for Operable Pancreatic CancerJAMA Network Open2022
Patterns of disease relapse and posttreatment follow‐up of patients with resected pancreatic adenocarcinoma: A single‐center analysisJournal of Surgical Oncology
Proton Therapy in the Management of Pancreatic CancerCancers2022
Interdisciplinary Approach of Establishing PDAC Resectability: Biochemical, Radiological and NAT Regimen Prognostic Factors—Literature ReviewMedicina (Lithuania)2022
Prediction of Margin‐Negative Resection of Pancreatic Ductal Adenocarcinoma Following Neoadjuvant Therapy: Diagnostic Performance of NCCN Criteria for Resection vs. CT‐Determined ResectabilityJournal of Hepato-Biliary-Pancreatic Sciences
The influence of UGT1A1 polymorphisms on modified FOLFIRINOX dose in double-variant-type patients with advanced pancreatic cancerInternational Journal of Clinical Oncology
The Next Frontier in Pancreatic Cancer: Targeting the Tumor Immune Milieu and Molecular PathwaysCancers2022
Stereotactic Ablative Radiotherapy Using CALYPSO® Extracranial Tracking for Intrafractional Tumor Motion Management—A New Potential Local Treatment for Unresectable Locally Advanced Pancreatic Cancer? Results from a Retrospective StudyCancers2022
PET-CT in Clinical Adult Oncology: III. Gastrointestinal MalignanciesCancers2022
Nationwide trends and outcomes of neoadjuvant chemotherapy in pancreatic cancer – an analysis of the Swedish national pancreatic cancer registryScandinavian Journal of Gastroenterology
Distal Pancreatectomy with En Bloc Celiac Axis Resection2022
Pancreaticoduodenectomy with Splenic Artery Resection for Tumors of the Pancreatic Head and/or Body Invading the Splenic Artery2022
The short-term outcomes of distal pancreatectomy with portal vein/superior mesenteric vein resectionLangenbeck's Archives of Surgery
Real‐world staging computed tomography scanning technique and important reporting discrepancies in pancreatic ductal adenocarcinomaANZ Journal of Surgery
Downstaging of Pancreatic Adenocarcinoma With Either Neoadjuvant Chemotherapy or Chemoradiotherapy Improves Survival.Annals of Surgical Oncology2022
A multimodality review of solid and cystic pancreatic masses
Intraoperative Pancreatic Neck Margin Assessment During Pancreaticoduodenectomy for Pancreatic Adenocarcinoma in the Era of Neoadjuvant Therapy: A Multi-institutional Analysis from the Central Pancreatic Consortium.Annals of Surgical Oncology2022
Response: Impact of Tumor Size on Outcomes for Patients with Resectable Distal Pancreatic Cancer.Annals of Surgical Oncology2022
Pancreatic Ductal Cell-Derived Extracellular Vesicles Are Effective Drug Carriers to Enhance Paclitaxel's Efficacy in Pancreatic Cancer Cells through Clathrin-Mediated Endocytosis.International Journal of Molecular Sciences2022
Real-world outcomes of adjuvant gemcitabine gemcitabine plus capecitabine for resected pancreatic ductal adenocarcinoma.Therapeutic Advances in Medical Oncology2022
Ablative Radiotherapy (ART) for Locally Advanced Pancreatic Cancer (LAPC): Toward a New Paradigm?Life2022
Data_Sheet_1.docx2019
Prognostic stratification in patients with pancreatic ductal adenocarcinoma after curative resection based on preoperative pancreatic contrast-enhanced CT findings.European Journal of Radiology2022
Prognosis following an extended duration of adjuvant gemcitabine plus S-1 chemotherapy in patients with pancreatic ductal adenocarcinoma: analysis using inverse probability of treatment weighting.Journal of Hepato-Biliary-Pancreatic Sciences2022
Modified FOLFIRINOX versus sequential chemotherapy (FOLFIRI/FOLFOX) as a second-line treatment regimen for unresectable pancreatic cancer: A real-world analysis.Cancer Medicine2021
The Association Between Neoadjuvant Therapy and Pathological Outcomes in Pancreatic Cancer Patients After Resection: Prognostic Significance of Microscopic Venous Invasion.Annals of Surgical Oncology2022
Induction therapy with Lu-DOTATATE procures long-term survival in locally advanced or oligometastatic pancreatic neuroendocrine neoplasm patients.European Journal of Nuclear Medicine and Molecular Imaging2022
ASO Author Reflections: The Survival Advantage Persists: Benefit of Adjuvant Chemotherapy in Resected, Stage IA Pancreatic Cancer.Annals of Surgical Oncology2022
Impact of the Cancer and Aging Research Group score and treatment intensity on survival and toxicity outcomes in older adults with advanced noncolorectal gastrointestinal cancers.Cancer2022
Deciphering the Etiology of Weight Loss Following Pancreatectomy.Annals of Surgical Oncology2022
Neoadjuvant Stereotactic Body Radiotherapy After Upfront Chemotherapy Improves Pathologic Outcomes Compared With Chemotherapy Alone for Patients With Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma Without Increasing Perioperative Toxicity.Annals of Surgical Oncology2022
Neoadjuvant Therapy Is Associated with Improved Chemotherapy Delivery and Overall Survival Compared to Upfront Resection in Pancreatic Cancer without Increasing Perioperative Complications.Cancers2022
Magnetic Resonance Imaging Radiomics-Based Nomogram From Primary Tumor for Pretreatment Prediction of Peripancreatic Lymph Node Metastasis in Pancreatic Ductal Adenocarcinoma: A Multicenter Study.Journal of Magnetic Resonance Imaging2022
Competing Risk Analysis of Outcomes of Unresectable Pancreatic Cancer Patients Undergoing Definitive Radiotherapy.Frontiers in Oncology2021
Molecular Features and Clinical Management of Hereditary Pancreatic Cancer Syndromes and Familial Pancreatic Cancer.International Journal of Molecular Sciences2022
Contemporary Assessment of Need for Palliative Bypass After Aborted Pancreatoduodenectomy Following Neoadjuvant Therapy.Journal of Gastrointestinal Surgery2022
MR-guided adaptive stereotactic body radiotherapy (SBRT) of primary tumor for pain control in metastatic pancreatic ductal adenocarcinoma (mPDAC): an open randomized, multicentric, parallel group clinical trial (MASPAC).Radiation Oncology2022
A novel event-free survival endpoint in locally advanced pancreatic cancerTherapeutic Advances in Medical Oncology2021
A novel method for predicting perineural invasion of distal cholangiocarcinoma on multidetector-row computed tomographySurgery Today2021
An Evaluation of Total Internal Motions of Locally Advanced Pancreatic Cancer during SABR Using Calypso Extracranial Tracking, and Its Possible Clinical Impact on Motion Management.Current Oncology2021
Real-world prognostic factors for survival among treated patients with metastatic pancreatic ductal adenocarcinomaCancer Medicine2021
Stereotactic Radiotherapy for Pancreatic Cancer: A Single-Institution ExperienceCureus2020
Staging of pancreatic cancer with multidetector CT in the setting of preoperative chemoradiation therapyAbdominal Imaging2006
Population pharmacokinetics of liposomal irinotecan in patients with cancer and exposure-safety analyses in patients with metastatic pancreatic cancerCPT: Pharmacometrics and Systems Pharmacology2021
Role of the microbiome in systemic therapy for pancreatic ductal adenocarcinoma (Review)International Journal of Oncology2021
Identification of intratumoral fluid-containing area by magnetic resonance imaging to predict prognosis in patients with pancreatic ductal adenocarcinoma after curative resectionEuropean Radiology2021
Cost-Effectiveness Analysis of Maintenance Olaparib in Patients with Metastatic Pancreatic Cancer and a Germline BRCA1/2 Mutation Based on the POLO TrialCancer Management and Research2020
Neoadjuvant Chemotherapy Switch in Borderline Resectable/Locally Advanced Pancreatic CancerAnnals of Surgical Oncology2021
Determining Hospital Volume Threshold for Safety of Minimally Invasive Pancreaticoduodenectomy: A Contemporary Cutpoint AnalysisAnnals of Surgical Oncology2021
Minimally invasive pancreatectomy for pancreatic cancerSuizo2021
ASO Author Reflections: Neoadjuvant Chemotherapy Switch: Optimizing Neoadjuvant Treatment Sequencing in Pancreas CancerAnnals of Surgical Oncology2021
Sarcopenia as a Predictor of Survival in Patients with Pancreatic Adenocarcinoma After PancreatectomyAnnals of Surgical Oncology2021
Validity of using cancer registry data for comparative effectiveness research
Use of Biosurgicals in Hepatobiliary Surgery
Clinical Staging of Pancreatic Cancer with MDCT and MRI2019
Role of 18F-Fluorodeoxyglucose Positron-Emission Tomography (FDG-PET) in the Management of Pancreatic Cancer2019
Importance of Carbohydrate Antigen 19-9 Monitoring in the Management of Pancreatic Cancer2019
Hybrid Imaging for Malignant Conditions of the Gastrointestinal Tract2019
The Future of Multidisciplinary Care in Pancreatic Cancer2019
Clinicopathological characteristics and therapeutic strategies of borderline resectable pancreatic carcinomaSuizo2018
Neoadjuvant Chemoradiation for Operable Pancreatic Cancer: The Importance of Local Disease Control2018
Cytotoxic Therapy in Advanced Pancreatic Cancer: Where We Are and Where We Are Headed2018
Distal Pancreatectomy with En Bloc Celiac Axis Resection (DP-CAR) for Advanced Pancreatic Body Cancer2017
Diagnostic Applications of Nuclear Medicine: Pancreatic Cancer2017
Pancreatic Resection After Neoadjuvant Treatment2017
Pancreatoduodenectomy with Concomitant Vascular Resection for Pancreas Cancer2017
Neoadjuvant Therapy for Pancreatic Cancer: a Review of the EvidenceJapanese Journal of Gastroenterological Surgery2017
Mesenteric Approach for Pancreaticoduodenectomy2017
Diagnostic Applications of Nuclear Medicine: Pancreatic Cancer2017
Diagnostic Applications of Nuclear Medicine: Pancreatic Cancer2017
Borderline Resectable Pancreatic Cancer2017
Comparisons between clinical guidelines for pancreatic cancer issued from ESMO, ASCO and NCCN and those from the JPS: A brief review of clinical problems of pancreatic cancerSuizo2017
The resectable pancreatic ductal adenocarcinoma: To FNA or not to FNA? A diagnostic dilemma, FNA prosEndoscopic Ultrasound2017
Diagnostic Applications of Nuclear Medicine: Pancreatic Cancer2016
Erlotinib for advanced pancreatic cancerThe Cochrane Library
Other Indications2015
Intraoperative and Laparoscopic Ultrasound During Pancreatic Surgery2014
Pyrimidine Antimetabolites☆2014
The current status of FOLFIRINOX for unresectable pancreatic cancerSuizo2014
Development of multidisciplinary therapy including surgical resection and chemotherapy for pancreatic cancer through clinical trialsSuizo2013
A Resected Case of Pancreatic Head Cancer Induced Duodenal Penetration and Bleeding During Neoadjuvant ChemoradiationJapanese Journal of Gastroenterological Surgery2013
A Case of Actinomycosis in a Patient Treated with Chemotherapy Due to Recurrent Pancreatic CancerKorean Journal of Medicine2013
Efficacy of postoperative adjuvant chemotherapy for pancreatic cancer and surgical outcome of borderline resectable pancreatic cancer with suspected arterial involvementSuizo2013
Positron emission tomography and computed tomography with [Ga]Ga-fibroblast activation protein inhibitors improves tumor detection and staging in patients with pancreatic cancerEuropean Journal of Nuclear Medicine and Molecular Imaging2021
Adjuvant Chemotherapy for Stage I Pancreatic Ductal Adenocarcinoma-Is It Based on Evidence or Clinical Wisdom?JAMA Oncology2021
Neoadjuvant therapy contributes to nodal downstaging of pancreatic cancerLangenbeck's Archives of Surgery2021
Adjuvant chemoradiotherapy for resected pancreas cancerWorld Journal of Gastrointestinal Surgery2010
The borderline resectable and locally advanced pancreatic ductal adenocarcinoma: DefinitionEndoscopic Ultrasound2017
Medical training fails to prepare providers to care for patients with chronic hepatitis B infectionWorld Journal of Gastroenterology2015
Optimal Preoperative Multidisciplinary Treatment in Borderline Resectable Pancreatic CancerCancers2020
MiRNA-615-5p functions as a tumor suppressor in pancreatic ductal adenocarcinoma by targeting AKT2PLoS ONE2015
An increased total resected lymph node count benefits survival following pancreas invasive intraductal papillary mucinous neoplasms resection: an analysis using the surveillance, epidemiology, and end result registry databasePLoS ONE2014
Neoadjuvant treatment strategies for resectable pancreas cancer: A propensity-matched analysis of the National Cancer DatabaseRadiotherapy and Oncology2020
Outcomes of Patients with Borderline Resectable Pancreatic Cancer Treated with Combination ChemotherapyJournal of Gastrointestinal Cancer2021
Recent advances in chemotherapy for pancreatic cancer: evidence from Japan and recommendations in guidelinesJournal of Gastroenterology2020
Exocrine Pancreas2017
Ampulla of Vater2017
Distal Bile Duct2017
Surgical Resection for Pancreatic Cancer2010
Clinical Significance of Germline Cancer Predisposing Variants in Unselected Patients with Pancreatic AdenocarcinomaCancers2021
Clinical impact of preoperative tumour contact with superior mesenteric-portal vein in patients with resectable pancreatic head cancerLangenbeck's Archives of Surgery2021
MR/MRCP for Diagnosis and Staging2021
ASO Author Reflections: Neoadjuvant Chemotherapy for Pancreatic Adenocarcinoma Lessens the Deleterious Effect of Omission of Adjuvant ChemotherapyAnnals of Surgical Oncology2021
Preoperative misdiagnosis of pancreatic and periampullary cancer in patients undergoing pancreatoduodenectomy: A multicentre retrospective cohort studyEuropean Journal of Surgical Oncology2021
Adjuvant Chemoradiotherapy in Resected Pancreatic Ductal Adenocarcinoma: Where Does the Benefit Lie? A Nomogram for Risk Stratification and Patient SelectionJournal of Gastrointestinal Surgery2021
Impact of conversion surgery on survival in locally advanced pancreatic cancer patients treated with FOLFIRINOX chemotherapyJournal of Hepato-Biliary-Pancreatic Sciences2021
Real-World Evaluation of Universal Germline Screening for Cancer Treatment-Relevant PharmacogenesCancers2021
A comparison of the guidelines for pancreatic cancer in Japan and the United StatesSuizo2021
Impact of Tumor Size on the Outcomes of Patients with Resectable Distal Pancreatic Cancer: Lessons Learned from a Series of 158 Radical ResectionsAnnals of Surgical Oncology2021
CT-diagnosed extra-pancreatic extension of pancreatic ductal adenocarcinoma is a more reliable prognostic factor for survival than pathology-diagnosed extensionEuropean Radiology2022
Systematic review and meta-analysis of diagnostic performance of CT imaging for assessing resectability of pancreatic ductal adenocarcinoma after neoadjuvant therapy: importance of CT criteriaAbdominal Radiology2021
Early-onset pancreatic cancer research: Making sense of confounding and biasCancer2021
GSK-3β in Pancreatic Cancer: Spotlight on 9-ING-41, Its Therapeutic Potential and Immune Modulatory PropertiesBiology2021
The importance of time-to-adjuvant treatment on survival with pancreatic cancer: A systematic review and meta-analysisCancer Reports2021
How to approach pancreatic cancer after neoadjuvant treatment: assessment of resectability using multidetector CT and tumor markersEuropean Radiology2022
Current Status of Treatment for Pancreatic Cancer in Japan and Prospects for the FutureNihon Ika Daigaku Igakkai Zasshi2021
HGF/c-Met Inhibition as Adjuvant Therapy Improves Outcomes in an Orthotopic Mouse Model of Pancreatic CancerCancers2021
The Landmark Series: Preoperative Therapy for Pancreatic CancerAnnals of Surgical Oncology2021
Association between time to stent dysfunction and the anti-tumour effect of systemic chemotherapy following stent placement in patients with pancreaticobiliary cancers and malignant gastric outlet obstruction: a retrospective cohort studyBMC Cancer2021
Impact of Neoadjuvant Therapy on Survival Following Margin-Positive Resection for Pancreatic CancerAnnals of Surgical Oncology2021
Pre-operative/Neoadjuvant Therapy and Vascular Debranching Followed by Resection for Locally Advanced Pancreatic Cancer (PREVADER): Clinical Feasibility TrialFrontiers in Medicine2021
Pancreatic adenocarcinoma: Beyond first line, where are we?World Journal of Gastroenterology2021
Laparoscopic pancreatectomy for cancer in high volume centers is associated with an increased use and fewer delays of adjuvant chemotherapyHpb2021
Evaluation of the validity of pancreatectomy for very elderly patients with pancreatic ductal adenocarcinomaLangenbeck's Archives of Surgery2021
Pancreatic ductal adenocarcinoma survival in South Australia: time trends and impact of tumour locationANZ Journal of Surgery2021
Risk Adapted Ablative Radiotherapy After Intensive Chemotherapy for Locally Advanced Pancreatic CancerFrontiers in Oncology2021
Atypical and uncommon CT and MR imaging presentations of pancreatic ductal adenocarcinomaAbdominal Radiology2021
Contemporary trials evaluating neoadjuvant therapy for resectable pancreatic cancerJournal of Surgical Oncology2021
Controversies in radiotherapy for pancreas cancerJournal of Surgical Oncology2021
Identification of Circulating Biomarkers and Construction of a Prognostic Signature for Survival Prediction in Locally Advanced Pancreatic Cancer After Irreversible ElectroporationJournal of Inflammation Research2021
Optimal Management of Resectable Pancreatic Head Cancer in the Elderly Patient: Does Neoadjuvant Therapy Offer a Survival Benefit?Annals of Surgical Oncology2021
Utility of mismatch repair protein expression screening via an endoscopic ultrasound assessment of treatment-naive pancreas ductal adenocarcinomaGut2022
Preoperative assessment of the resectability of pancreatic ductal adenocarcinoma on CT according to the NCCN Guidelines focusing on SMA/SMV branch invasionEuropean Radiology2021
Radiotherapy for locally advanced pancreatic ductal adenocarcinomaSeminars in Oncology2021
Role of Endoscopic Ultrasonography and Endoscopic Retrograde Cholangiopancreatography in the Diagnosis of Pancreatic CancerDiagnostics2021
Preceding Systemic Chemotherapy for Patients with Pancreatic Ductal Adenocarcinoma with Positive Peritoneal Cytology Provides Survival Benefit Compared with Up-Front SurgeryAnnals of Surgical Oncology2021
Surgical Feasibility, Determinants, and Overall Efficacy of Neoadjuvant Lu-DOTATATE PRRT for Locally Advanced Unresectable Gastroenteropancreatic Neuroendocrine TumorsJournal of Nuclear Medicine2021
A Highly Responsive Pancreatic Ductal Adenocarcinoma with Liver Metastasis: A Rare Case ReportInternational Journal of General Medicine2021
Neoadjuvant therapy is associated with lower margin positivity rates after Pancreaticoduodenectomy in T1 and T2 pancreatic head cancers: An analysis of the National Cancer DatabaseSurgery Open Science2021
Neoadjuvant Chemotherapy for Pancreatic Adenocarcinoma Lessens the Deleterious Effect of Omission of Adjuvant ChemotherapyAnnals of Surgical Oncology2021
CT-determined resectability of borderline resectable and unresectable pancreatic adenocarcinoma following FOLFIRINOX therapyEuropean Radiology2021
CT in the prediction of margin-negative resection in pancreatic cancer following neoadjuvant treatment: a systematic review and meta-analysisEuropean Radiology2021
Neoadjuvant chemoradiation is associated with decreased lymph node ratio in borderline resectable pancreatic cancer: A propensity score matched analysisHepatobiliary and Pancreatic Diseases International2021